 Print page |
 Email page |
| FOR IMMEDIATE RELEASE Oct. 11, 2006 |
Contact: Jennifer Reising at jreising@reisingcommunications.com |
The Latest Findings in Thyroid Disease and a Free Health Event for the
Public
Are Focus of Thyroid Specialist Meeting in Phoenix
(PHOENIX)—The latest research findings in thyroid disease along with the newest information in diagnosis and clinical management will be the highlights of the American Thyroid Association’s (ATA) 77th Annual Meeting, Oct. 11–15, 2006, at the Sheraton Wild Horse Pass Spa and Resort in Phoenix. The meeting will bring together experts in thyroid health from the United States and around the world.
Patient Information From Experts and Patients
The public is invited to a free educational forum on thyroid disorders
and their treatment that will be held on Saturday, Oct. 14, from 1:00
p.m. – 4:00 p.m. at the Sheraton, 5594 West Wild Horse Pass Boulevard,
15 miles south of downtown Phoenix. Thyroid experts and patients will
be on hand to answer questions from patients, their families, and other
attendees. This forum is presented by the ATA Alliance for Thyroid Patient
Education, which includes the ATA, the Thyroid Foundation of America,
ThyCa: Thyroid Cancer Survivors’ Association, the Light of Life
Foundation, and the National Graves’ Disease Foundation. Reservations
are requested by phone, 800-832-8321, or e-mail, thyca@thyca.org, but
walk-ins are welcome.
New Insights on Thyroid Patient Care
In addition to new research being presented at the meeting, respected
experts will also be presenting key information on —
- Advanced Ultrasound Symposium and Practicum: A hands-on session taking a broad look at the uses of ultrasound in thyroid care and led by local Phoenix thyroid specialist Dan Duick, MD, Oct. 11, 1:00 p.m.–5:00 p.m.
- Thyroid Hormone Receptor: 20 years of Discovery – This plenary session includes Ronald M. Evans, PhD, and Björn Vennström, PhD, the two scientists whose laboratories first cloned the thyroid hormone receptor. Dr. Evans, a 2004 Lasker Award recipient, is known for his discovery of the superfamily of genes encoding nuclear receptor hormone receptors and the elucidation of their universal mechanism of action. He is listed by the Institute of Scientific Information as one of the 10 most cited scientists of the past two decades. Dr. Vennström, of the Karolinska Institute in Stockholm, and colleagues have identified the roles of thyroid hormone receptors alpha and beta in mediating the diverse functions of thyroid hormone, Oct. 12, 10:30 a.m.–noon.
- New insights into treatment decisions for milder thyroid disease: Examining effects on cognitive function, cardiovascular risk, and pregnancy, with the evaluation of current treatment guidelines, Oct. 13, 6:30 a.m.–7:45 a.m.
- Thyroid Grand Rounds: Examining whether all nodules greater than 1 cm require fine needle aspiration, Oct. 13, 4:00 p.m.–5:15 p.m.
- Graves’ disease: Discussing diagnosis and treatment issues in fetal, pediatric, and adult cases, Oct. 14, 10:45 a.m.–noon
- Public Health and the Thyroid: Reviewing the issues surrounding thyroxine bioequivalence and potassium iodide distribution for thyroid protection, Oct. 15, 8:25 a.m.–9:40 a.m.
Fellows Track
The ATA is offering its annual program for endocrine fellows as part of
the Annual Meeting. This targeted track will provide fellows with opportunities
for skill enhancement and give them insight into a broad range of thyroid
care issues as well as offer hands-on experience with ultrasound machines
and access to technicians and respected leaders in the field.
For more information about the ATA and the new research being presented at the Annual Meeting, go to www.thyroid.org.
The American Thyroid Association is a nonprofit professional medical
society composed of physicians and scientists dedicated to enhancing the
understanding of thyroid physiology and pathophysiology, improving diagnosis
and treatment of thyroid diseases, and promoting the education of physicians,
patients, and the public about thyroid disorders.
# # #
